X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-09-18 | AURX | Nuo Therapeutics, Inc. | Sheedy Charles E | 10% | P - Purchase | $0.75 | +125,000 | 11,440,865 | +1% | +$93,750 | ||||||
2024-09-12 | LUNG | Pulmonx Corp | French Glendon E. III | Dir | S - Sale | $8.09 | -20,000 | 1,111,974 | -2% | -$161,800 | ||||||
| D | 2024-09-16 | PRCT | Procept Biorobotics Corp | Waters Kevin | EVP, CFO | S - Sale+OE | $82.51 | -25,000 | 96,096 | -21% | -$2,062,679 | |||||
2024-09-16 | NARI | Inari Medical, Inc. | Hoffman William | Dir | S - Sale | $45.83 | -40,000 | 643,296 | -6% | -$1,833,188 | ||||||
2024-09-16 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.90 | +450 | 15,475,195 | 0% | +$404 | ||||||
| DM | 2024-09-13 | SYK | Stryker Corp | Fink M Kathryn | VP, CHRO | S - Sale+OE | $367.66 | -9,468 | 10,440 | -48% | -$3,480,956 | |||||
2024-09-16 | TMCI | Treace Medical Concepts, Inc. | Treace John T. | CEO, 10% | P - Purchase | $5.31 | +50,000 | 11,847,224 | 0% | +$265,630 | ||||||
2024-09-13 | TTOO | T2 Biosystems, Inc. | Elsbree David B | Dir | S - Sale | $2.42 | -55 | 25 | -69% | -$133 | ||||||
| D | 2024-09-13 | GMED | Globus Medical Inc | Rhoads Ann D | Dir | S - Sale+OE | $70.36 | -15,000 | 42,884 | -26% | -$1,055,400 | |||||
| D | 2024-09-13 | GMED | Globus Medical Inc | Davidar David D | Dir | S - Sale+OE | $70.46 | -25,000 | 772,242 | -3% | -$1,761,500 | |||||
2024-09-16 | DXCM | Dexcom Inc | Heller Bridgette P | Dir | S - Sale | $70.00 | -1,000 | 24,349 | -4% | -$70,000 | ||||||
2024-09-13 | PSTV | Plus Therapeutics, Inc. | Hawkins Richard J | Dir | P - Purchase | $1.50 | +4,000 | 15,188 | +36% | +$5,996 | ||||||
2024-09-13 | CTCX | Carmell Corp | Upton Richard A | Dir | P - Purchase | $0.47 | +5,000 | 1,432,279 | 0% | +$2,336 | ||||||
2024-09-12 | PSTV | Plus Therapeutics, Inc. | Hawkins Richard J | Dir | P - Purchase | $1.35 | +6,285 | 11,188 | +128% | +$8,512 | ||||||
| D | 2024-09-12 | GUTS | Fractyl Health, Inc. | Caplan Jay David | Pres, Chief Product Officer | S - Sale+OE | $2.90 | -65,000 | 508,100 | -11% | -$188,474 | |||||
| M | 2024-09-12 | TLSI | Trisalus Life Sciences, Inc. | Szela Mary T | CEO, Pres | P - Purchase | $5.09 | +14,815 | 384,677 | +4% | +$75,359 | |||||
2024-09-12 | STIM | Neuronetics, Inc. | Cascella Robert | Dir | P - Purchase | $0.75 | +100,000 | 453,098 | +28% | +$75,000 | ||||||
| D | 2024-09-12 | NARI | Inari Medical, Inc. | Hill, Mitch C. | CFO | S - Sale+OE | $45.13 | -3,000 | 181,200 | -2% | -$135,385 | |||||
| D | 2024-09-12 | RMD | Resmed Inc | Ghoshal Kaushik | Chief Commercial Officer, SaaS | S - Sale+OE | $252.56 | -5,000 | 21,788 | -19% | -$1,262,800 | |||||
2024-09-11 | PSTV | Plus Therapeutics, Inc. | Petersen Greg | Dir | P - Purchase | $1.35 | +12,500 | 48,921 | +34% | +$16,875 | ||||||
2024-09-11 | PSTV | Plus Therapeutics, Inc. | Clowes Howard | Dir | P - Purchase | $1.34 | +5,000 | 26,497 | +23% | +$6,681 | ||||||
| M | 2024-09-10 | PRCT | Procept Biorobotics Corp | Desai Antal Rohit | Dir | S - Sale | $78.09 | -120,065 | 197,453 | -38% | -$9,375,595 | |||||
2024-09-10 | TLSI | Trisalus Life Sciences, Inc. | Szela Mary T | CEO, Pres | P - Purchase | $4.97 | +5,000 | 369,862 | +1% | +$24,850 | ||||||
| M | 2024-09-10 | DRIO | Dariohealth Corp. | Nelson Steven Charles | Chief Commercial Officer | P - Purchase | $0.82 | +10,000 | 50,000 | +25% | +$8,244 | |||||
| D | 2024-09-11 | PODD | Insulet Corp | Hopfield Jessica | Dir | S - Sale+OE | $225.26 | -7,628 | 26,917 | -22% | -$1,718,283 | |||||
2024-08-27 | HRGN | Harvard Apparatus Regenerative Technology, Inc. | He Junli | CEO | P - Purchase | $3.37 | +5,101 | 259,701 | +2% | +$17,190 | ||||||
| D | 2024-09-09 | GKOS | Glaukos Corp | Kliman Gilbert H | Dir | S - Sale+OE | $130.67 | -3,000 | 32,336 | -8% | -$392,000 | |||||
2024-09-09 | DXCM | Dexcom Inc | Stern Sadie | EVP, CHRO | S - Sale | $69.15 | -426 | 75,451 | -1% | -$29,458 | ||||||
2024-09-09 | DXCM | Dexcom Inc | Sylvain Jereme M | EVP, Chief Financal Officer | S - Sale | $69.15 | -746 | 84,274 | -1% | -$51,586 | ||||||
2024-09-09 | DXCM | Dexcom Inc | Leach Jacob Steven | EVP, COO | S - Sale | $69.15 | -746 | 312,211 | 0% | -$51,586 | ||||||
| M | 2024-09-09 | SSII | Ss Innovations International, Inc. | Cohen Barry F | COO - Americas | P - Purchase | $3.91 | +622 | 8,959,903 | 0% | +$2,430 | |||||
2024-09-09 | INSP | Inspire Medical Systems, Inc. | McCormick Shawn | Dir | S - Sale | $220.00 | -800 | 26,140 | -3% | -$176,000 | ||||||
2024-09-09 | INSP | Inspire Medical Systems, Inc. | Rondoni John | CTO | S - Sale | $215.00 | -31 | 11,348 | 0% | -$6,665 | ||||||
| D | 2024-09-06 | BEAT | Heartbeam, Inc. | De Urioste George | Dir | S - Sale+OE | $2.34 | -1,674 | 57,146 | -3% | -$3,917 | |||||
2024-09-10 | PODD | Insulet Corp | Scannell Timothy J | Dir | S - Sale | $225.84 | -5,000 | 30,586 | -14% | -$1,129,200 | ||||||
2024-09-10 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.91 | +8,577 | 15,474,745 | 0% | +$7,812 | ||||||
2024-09-10 | PSTV | Plus Therapeutics, Inc. | Hedrick Marc H | CEO | P - Purchase | $1.23 | +8,000 | 20,425 | +64% | +$9,839 | ||||||
2024-09-10 | PSTV | Plus Therapeutics, Inc. | Sims Andrew John Hugh Macintyre | CFO | P - Purchase | $1.27 | +4,098 | 9,815 | +72% | +$5,204 | ||||||
2024-09-09 | RMD | Resmed Inc | Sandercock Brett | CFO | S - Sale | $246.42 | -1,000 | 96,812 | -1% | -$246,420 | ||||||
| D | 2024-09-09 | RMD | Resmed Inc | Farrell Michael J. | CEO | S - Sale+OE | $248.38 | -14,683 | 468,259 | -3% | -$3,646,950 | |||||
| M | 2024-09-09 | OBIO | Orchestra Biomed Holdings, Inc. | Sherman Darren | See Remarks | S - Sale | $5.39 | -13,708 | 1,538,478 | -1% | -$73,946 | |||||
| M | 2024-09-06 | OBIO | Orchestra Biomed Holdings, Inc. | Fain Eric S | Dir | S - Sale | $5.48 | -5,600 | 86,020 | -6% | -$30,666 | |||||
2024-08-28 | TLSI | Trisalus Life Sciences, Inc. | Martin George Kelly | Dir | S - Sale | $5.50 | -9 | 247,176 | 0% | -$50 | ||||||
2024-09-06 | CTCX | Carmell Corp | Gregory Kathryn | Dir | P - Purchase | $0.51 | +1,260 | 84,757 | +2% | +$643 | ||||||
2024-09-06 | CTCX | Carmell Corp | Sturgeon Patrick A | Dir | P - Purchase | $0.51 | +1,261 | 135,910 | +1% | +$643 | ||||||
2024-09-10 | CTCX | Carmell Corp | Cassaday Bryan J. | CFO | P - Purchase | $0.46 | +475 | 35,500 | +1% | +$219 | ||||||
2024-09-06 | CTCX | Carmell Corp | Frisch Scott M. | Dir | P - Purchase | $0.51 | +1,009 | 28,419 | +4% | +$515 | ||||||
2024-09-06 | CTCX | Carmell Corp | Spenlehauer Gilles | Dir | P - Purchase | $0.51 | +1,009 | 28,419 | +4% | +$515 | ||||||
2024-09-09 | PODD | Insulet Corp | Field Mark N | SVP, CTO | S - Sale | $220.87 | -1,383 | 9,761 | -12% | -$305,463 | ||||||
2024-09-09 | PODD | Insulet Corp | Budden Lauren | Group VP, CAO, Controller | S - Sale | $221.41 | -1,506 | 6,609 | -19% | -$333,443 | ||||||
| M | 2024-09-05 | DRIO | Dariohealth Corp. | Nelson Steven Charles | Chief Commercial Officer | P - Purchase | $0.82 | +15,000 | 40,000 | +60% | +$12,292 | |||||
| M | 2024-09-04 | OBIO | Orchestra Biomed Holdings, Inc. | Sherman Darren | See Remarks | S - Sale | $5.87 | -20,617 | 1,572,770 | -1% | -$120,955 | |||||
2024-09-05 | STIM | Neuronetics, Inc. | Muir Glenn P | Dir | P - Purchase | $0.80 | +25,000 | 289,818 | +9% | +$20,000 | ||||||
2024-09-04 | ARAY | Accuray Inc | Pervaiz Ali | SVP CFO | S - Sale | $2.06 | -8,404 | 394,138 | -2% | -$17,276 | ||||||
| D | 2024-09-05 | BSX | Boston Scientific Corp | Mahoney Michael F | COB, Pres, CEO | S - Sale+OE | $81.17 | -162,777 | 1,832,265 | -8% | -$13,212,544 | |||||
2024-09-04 | RMD | Resmed Inc | Farrell Peter C | Dir | S - Sale | $239.90 | -2,000 | 87,204 | -2% | -$479,800 | ||||||
2024-09-05 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.91 | +5,251 | 15,466,168 | 0% | +$4,799 | ||||||
2024-09-03 | LNSR | Lensar, Inc. | Winer Gary M | Dir | P - Purchase | $4.50 | +685 | 80,840 | +1% | +$3,083 | ||||||
2024-09-03 | PEN | Penumbra Inc | Roberts Johanna | EVP, Gen. Counsel, Secretary | S - Sale | $206.22 | -600 | 61,088 | -1% | -$123,733 | ||||||
2024-09-04 | PEN | Penumbra Inc | Grewal Harpreet | Dir | S - Sale | $204.11 | -782 | 8,863 | -8% | -$159,614 | ||||||
| M | 2024-09-03 | PRCT | Procept Biorobotics Corp | Desai Antal Rohit | Dir | S - Sale | $75.78 | -102,157 | 324,061 | -24% | -$7,741,893 | |||||
2024-09-03 | LUNG | Pulmonx Corp | Rose Geoffrey Beran | Chief Commercial Officer | S - Sale | $6.70 | -4,586 | 295,433 | -2% | -$30,721 | ||||||
2024-09-03 | LUNG | Pulmonx Corp | Lehman David Aaron | GC | S - Sale | $6.69 | -5,765 | 203,348 | -3% | -$38,576 | ||||||
| M | 2024-09-03 | CERS | Cerus Corp | Green Kevin Dennis | CFO | S - Sale | $2.16 | -82,657 | 536,093 | -13% | -$178,745 | |||||
2024-08-30 | CTCX | Carmell Corp | Gregory Kathryn | Dir | P - Purchase | $0.57 | +109 | 83,497 | 0% | +$62 | ||||||
| D | 2024-08-30 | BEAT | Heartbeam, Inc. | De Urioste George | Dir | S - Sale+OE | $2.31 | -5,500 | 58,820 | -9% | -$12,705 | |||||
2024-09-03 | SIBN | Si-Bone, Inc. | Maheshwari Anshul | CFO | S - Sale | $16.35 | -1,414 | 200,367 | -1% | -$23,119 | ||||||
2024-08-30 | CTCX | Carmell Corp | Frisch Scott M. | Dir | P - Purchase | $0.57 | +87 | 25,809 | 0% | +$50 | ||||||
2024-08-30 | CTCX | Carmell Corp | Sturgeon Patrick A | Dir | P - Purchase | $0.57 | +109 | 133,048 | 0% | +$62 | ||||||
2024-08-30 | CTCX | Carmell Corp | Spenlehauer Gilles | Dir | P - Purchase | $0.57 | +87 | 25,809 | 0% | +$50 | ||||||
2024-09-03 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.92 | +15,096 | 15,460,917 | 0% | +$13,937 | ||||||
| D | 2024-09-03 | ICUI | Icu Medical Inc/de | Jain Vivek | COB, CEO | S - Sale+OE | $163.46 | -12,000 | 193,291 | -6% | -$1,961,540 | |||||
| D | 2024-09-03 | BSX | Boston Scientific Corp | Carruthers Wendy | EVP, HR | S - Sale+OE | $81.70 | -6,983 | 37,468 | -16% | -$570,511 | |||||
2024-08-30 | PODD | Insulet Corp | Singh Prem | SVP, Global Operations | S - Sale | $202.27 | -1,824 | 3,656 | -33% | -$368,940 | ||||||
2024-08-30 | DXCM | Dexcom Inc | Brown Michael Jon | EVP, GC | S - Sale | $70.00 | -686 | 65,636 | -1% | -$48,020 | ||||||
2024-08-29 | ECIA | Encision Inc | Fries Robert H | Dir | P - Purchase | $0.37 | +35,000 | 590,000 | +6% | +$12,880 | ||||||
2024-08-30 | ICUI | Icu Medical Inc/de | Woolson Daniel | VP, GM-Infusion Capital | S - Sale | $163.22 | -2,502 | 13,107 | -16% | -$408,370 | ||||||
| M | 2024-08-28 | STIM | Neuronetics, Inc. | Muir Glenn P | Dir | P - Purchase | $0.85 | +25,000 | 264,818 | +10% | +$21,250 | |||||
| M | 2024-08-28 | CTCX | Carmell Corp | Sturgeon Patrick A | Dir | P - Purchase | $0.56 | +1,622 | 132,939 | +1% | +$908 | |||||
| M | 2024-08-28 | CTCX | Carmell Corp | Frisch Scott M. | Dir | P - Purchase | $0.56 | +1,121 | 25,722 | +5% | +$628 | |||||
| M | 2024-08-28 | CTCX | Carmell Corp | Gregory Kathryn | Dir | P - Purchase | $0.56 | +1,736 | 83,388 | +2% | +$972 | |||||
2024-08-29 | CTCX | Carmell Corp | Cassaday Bryan J. | CFO | P - Purchase | $0.57 | +1,000 | 35,025 | +3% | +$570 | ||||||
| M | 2024-08-28 | CTCX | Carmell Corp | Anderson David W | Dir | P - Purchase | $0.56 | +1,401 | 77,632 | +2% | +$785 | |||||
| M | 2024-08-28 | CTCX | Carmell Corp | Spenlehauer Gilles | Dir | P - Purchase | $0.56 | +1,121 | 25,722 | +5% | +$628 | |||||
2024-08-27 | CTCX | Carmell Corp | Gregory Kathryn | Dir | P - Purchase | $0.71 | +2,413 | 80,369 | +3% | +$1,713 | ||||||
2024-08-27 | CTCX | Carmell Corp | Sturgeon Patrick A | Dir | P - Purchase | $0.71 | +1,587 | 131,317 | +1% | +$1,127 | ||||||
| D | 2024-08-27 | BEAT | Heartbeam, Inc. | De Urioste George | Dir | S - Sale+OE | $2.26 | -2,194 | 64,320 | -3% | -$4,958 | |||||
2024-08-29 | PODD | Insulet Corp | Chadwick Ana Maria | EVP, CFO, Treasurer | P - Purchase | $206.00 | +100 | 13,314 | +1% | +$20,600 | ||||||
2024-08-28 | PODD | Insulet Corp | Field Mark N | SVP, CTO | S - Sale | $203.00 | -1,387 | 11,347 | -11% | -$281,561 | ||||||
2024-08-28 | BSX | Boston Scientific Corp | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | S - Sale | $80.00 | -14,132 | 181,249 | -7% | -$1,130,560 | ||||||
| M | 2024-08-26 | LNSR | Lensar, Inc. | Winer Gary M | Dir | P - Purchase | $4.51 | +2,302 | 80,155 | +3% | +$10,373 | |||||
2024-08-27 | DRIO | Dariohealth Corp. | Raphael Erez | CEO | P - Purchase | $0.88 | +5,000 | 1,974,935 | 0% | +$4,400 | ||||||
| D | 2024-08-23 | NXGL | Nexgel, Inc. | Stein John Nachum | Dir | P - Purchase | $2.50 | +10,000 | 471,820 | +2% | +$25,000 | |||||
| M | 2024-08-26 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.94 | +8,881 | 15,445,821 | 0% | +$8,375 | |||||
| D | 2024-08-23 | NXGL | Nexgel, Inc. | Glassman Steven Mark | Dir | P - Purchase | $2.50 | +10,000 | 145,025 | +7% | +$25,000 | |||||
| D | 2024-08-23 | NXGL | Nexgel, Inc. | Zeldis Jerome B | Dir | P - Purchase | $2.50 | +10,000 | 103,028 | +11% | +$25,000 | |||||
| D | 2024-08-23 | NXGL | Nexgel, Inc. | Henry Scott Robert | Dir | P - Purchase | $2.50 | +10,000 | 145,735 | +7% | +$25,000 | |||||
| D | 2024-08-23 | NXGL | Nexgel, Inc. | Drapczuk Adam E III | CFO | P - Purchase | $2.50 | +10,000 | 82,494 | +14% | +$25,000 | |||||
2024-08-27 | SYK | Stryker Corp | Menon Viju | Group Pres | S - Sale | $355.00 | -600 | 9,245 | -6% | -$213,000 | ||||||
2024-08-26 | AORT | Artivion, Inc. | Holloway Jean F | SVP, GC | S - Sale | $26.55 | -3,167 | 161,932 | -2% | -$84,096 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |